Latest news
Akeso Doses First Patient in Phase 2 Trial of Bispecific ADC AK146D1 Plus Ivonescimab in Breast Cancer - BioPharm InternationalBioPharm International · Mon, 10 Aug 2026 16:47:15 GMTAddressing Manufacturing and Access Barriers in Advanced Therapeutics - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTNavigating Biopharma Complexity: Why Long-Term Partnerships Matter - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 10:28:23 GMT